| Daryl Jordan Yann, | |
|
100 N Green Valley Pkwy Ste 239, Henderson, NV 89074-7704 | |
| (702) 910-3950 | |
| Not Available |
| Full Name | Daryl Jordan Yann |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 100 N Green Valley Pkwy Ste 239, Henderson, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134607237 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 812422 (Nevada) | Primary |
| Entity Name | Medtrans Behavioral Nevada Casal Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245781160 PECOS PAC ID: 7810259165 Enrollment ID: O20180326001159 |
News Archive
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.
Pacira Pharmaceuticals, Inc. today announced results of an independent, physician-initiated study designed to evaluate the difference in postsurgical pain and opioid consumption between patients who received EXPAREL versus a multi-drug analgesic cocktail for pain management following total knee arthroplasty (TKA).
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
› Verified 6 days ago
| Entity Name | Medtrans |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871915892 PECOS PAC ID: 9739437815 Enrollment ID: O20180806002709 |
News Archive
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.
Pacira Pharmaceuticals, Inc. today announced results of an independent, physician-initiated study designed to evaluate the difference in postsurgical pain and opioid consumption between patients who received EXPAREL versus a multi-drug analgesic cocktail for pain management following total knee arthroplasty (TKA).
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
› Verified 6 days ago
| Entity Name | Medtrans Medical Nevada Casal Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750846549 PECOS PAC ID: 1850632365 Enrollment ID: O20190410002272 |
News Archive
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.
Pacira Pharmaceuticals, Inc. today announced results of an independent, physician-initiated study designed to evaluate the difference in postsurgical pain and opioid consumption between patients who received EXPAREL versus a multi-drug analgesic cocktail for pain management following total knee arthroplasty (TKA).
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
› Verified 6 days ago
| Entity Name | Kilmaley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538703384 PECOS PAC ID: 1052744596 Enrollment ID: O20191213001636 |
News Archive
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.
Pacira Pharmaceuticals, Inc. today announced results of an independent, physician-initiated study designed to evaluate the difference in postsurgical pain and opioid consumption between patients who received EXPAREL versus a multi-drug analgesic cocktail for pain management following total knee arthroplasty (TKA).
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
› Verified 6 days ago
| Entity Name | Trinity House Calls Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083396733 PECOS PAC ID: 7416302419 Enrollment ID: O20231011002411 |
News Archive
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.
Pacira Pharmaceuticals, Inc. today announced results of an independent, physician-initiated study designed to evaluate the difference in postsurgical pain and opioid consumption between patients who received EXPAREL versus a multi-drug analgesic cocktail for pain management following total knee arthroplasty (TKA).
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daryl Jordan Yann, 3312 W Charleston Blvd, Las Vegas, NV 89102-1829 Ph: (702) 971-2300 | Daryl Jordan Yann, 100 N Green Valley Pkwy Ste 239, Henderson, NV 89074-7704 Ph: (702) 910-3950 |
News Archive
Physicians can now be alerted to pediatric patients' risk of sudden unexpected death in epilepsy, or SUDEP, during routine primary care visits by using software developed and commercialized by a researcher-entrepreneur at the Indiana University School of Medicine.
Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the third quarter ended June 30, 2011.
Pacira Pharmaceuticals, Inc. today announced results of an independent, physician-initiated study designed to evaluate the difference in postsurgical pain and opioid consumption between patients who received EXPAREL versus a multi-drug analgesic cocktail for pain management following total knee arthroplasty (TKA).
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
According to Health Minister Nicola Roxon, expensive drugs have never been automatically listed for subsidy and they can't be now when the government controlling expenses. She added that federal Labor has to balance competing priorities in health and every other department.
› Verified 6 days ago
Lydia Glaude, PHD, RN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2662 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-616-9660 | |
Mrs. Edith Lamira Odiwo, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2200 Paseo Verde Pkwy Ste 190, Henderson, NV 89052 Phone: 702-589-4871 Fax: 702-589-4872 | |
Martha Kim, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9065 S Pecos Rd Ste 190, Henderson, NV 89074 Phone: 702-888-3148 | |
Crystal Celeste Huffaker, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1655 W Horizon Ridge Pkwy, Henderson, NV 89012 Phone: 702-476-9999 Fax: 702-946-1343 | |
Ms. Markquetta Renee Jackson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2200 Paseo Verde Pkwy Ste 190, Henderson, NV 89052 Phone: 702-589-4871 | |
Odelaysis Padron-oramas, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 W Sunset Rd Ste 102, Henderson, NV 89011 Phone: 725-241-5252 Fax: 725-231-7474 | |
Natalie Mason, MSN, RN, PNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2350 W Horizon Ridge Pkwy, Henderson, NV 89052 Phone: 702-564-8556 Fax: 702-564-4485 |